Literature DB >> 7872767

Antimicrobial resistance of Shigella isolates causing traveler's diarrhea.

J Vila1, J Gascon, S Abdalla, J Gomez, F Marco, A Moreno, M Corachan, T Jimenez de Anta.   

Abstract

Shigella isolates were identified as a cause of traveler's diarrhea in 67 (10%) of 675 patients and were tested for resistance to seven antimicrobial agents in a comparative study with those causing nontraveler's diarrhea in Spain. Ampicillin and chloramphenicol resistance was more frequent in Shigella flexneri (60 and 46%, respectively) than in Shigella sonnei (32 and 18%, respectively) and in travel-related isolates (P < 0.05 and 0.04, respectively). Of S. sonnei isolates from patients with traveler's diarrhea, 73 and 54% showed tetracycline and trimethoprim-sulfamethoxazole resistance, respectively, compared with only 8% of isolates from patients without a history of travel to developing countries (P < 0.007 and P < 0.0002). Low-level resistance to cephalosporins was found, whereas quinolone-resistant strains were not detected among travel-related Shigella isolates. Thus, quinolones may be an effective alternative therapy for travel-related shigellosis.

Entities:  

Mesh:

Year:  1994        PMID: 7872767      PMCID: PMC188262          DOI: 10.1128/AAC.38.11.2668

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Estimating worldwide current antibiotic usage: report of Task Force 1.

Authors:  N F Col; R W O'Connor
Journal:  Rev Infect Dis       Date:  1987 May-Jun

2.  Clinical and bacteriological evaluation of antibiotic treatment in shigellosis.

Authors:  M J Tong; D G Martin; J J Cunningham; J J Gunning
Journal:  JAMA       Date:  1970-12-07       Impact factor: 56.272

3.  Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.

Authors:  E Gotuzzo; R A Oberhelman; C Maguiña; S J Berry; A Yi; M Guzman; R Ruiz; R Leon-Barua; R B Sack
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress.

Authors:  M H Merson; G K Morris; D A Sack; J G Wells; J C Feeley; R B Sack; W B Creech; A Z Kapikian; E J Gangarosa
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

5.  Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention.

Authors:  A A Ries; J G Wells; D Olivola; M Ntakibirora; S Nyandwi; M Ntibakivayo; C B Ivey; K D Greene; F C Tenover; S P Wahlquist
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

6.  Antibiotic treatment of acute shigellosis: failure of cefamandole compared with trimethoprim/ sulfamethoxazole and ampicillin.

Authors:  W A Orenstein; L Ross; G D Overturf; J Wilkins; D R Redfield; A Underman
Journal:  Am J Med Sci       Date:  1981 Jul-Aug       Impact factor: 2.378

7.  Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.

Authors:  P De Mol; T Mets; R Lagasse; J Vandepitte; A Mutwewingabo; J P Butzler
Journal:  J Antimicrob Chemother       Date:  1987-05       Impact factor: 5.790

8.  Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial.

Authors:  I Kabir; T Butler; A Khanam
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

9.  Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.

Authors:  H L DuPont; R R Reves; E Galindo; P S Sullivan; L V Wood; J G Mendiola
Journal:  N Engl J Med       Date:  1982-09-30       Impact factor: 91.245

10.  Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery.

Authors:  M Yunus; A S Mizanur Rahman; A S Farooque; R I Glass
Journal:  J Trop Med Hyg       Date:  1982-10
View more
  13 in total

1.  Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea.

Authors:  M Vargas; J Gascon; M T Jimenez De Anta; J Vila
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Rapid detection of Shigella species in environmental sewage by an immunocapture PCR with universal primers.

Authors:  Xuanxian Peng; Wen Luo; Jianying Zhang; Sanying Wang; Shengcai Lin
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

3.  Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea.

Authors:  J Vila; M Vargas; J Ruiz; F Gallardo; M T Jimenez de Anta; J Gascón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona.

Authors:  G Prats; B Mirelis; T Llovet; C Muñoz; E Miró; F Navarro
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania.

Authors:  M M Navia; L Capitano; J Ruiz; M Vargas; H Urassa; D Schellemberg; J Gascon; J Vila
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.

Authors:  Carlos Toro; Ana Arroyo; Ana Sarria; Nuria Iglesias; Ana Enríquez; Margarita Baquero; Concepción Ladrón de Guevara
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

7.  Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.

Authors:  Roberto Cabrera; Joaquím Ruiz; Francesc Marco; Inés Oliveira; Margarita Arroyo; Ana Aladueña; Miguel A Usera; M Teresa Jiménez De Anta; Joaquím Gascón; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Epidemiology of nalidixic acid resistance and TEM-1- and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000.

Authors:  Young Sook Jeong; Je Chul Lee; Hee Young Kang; Hak Sun Yu; Eun Young Lee; Chul Hee Choi; Seong Ho Tae; Yoo Chul Lee; Dong Taek Cho; Sung Yong Seol
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Changes in patterns of antimicrobial susceptibility and integron carriage among Shigella sonnei isolates from southwestern Korea during epidemic periods.

Authors:  Jae Young Oh; Hak Sun Yu; Sung Ki Kim; Seong Yong Seol; Dong Taek Cho; Je Chul Lee
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 10.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.